Brainstorm Cell Therapeutics Inc (BCLI)
0.525
-0.02
(-2.80%)
USD |
NASDAQ |
Apr 23, 16:00
0.5323
+0.01
(+1.39%)
After-Hours: 20:00
Brainstorm Cell Therapeutics Free Cash Flow (Quarterly): -3.285M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.285M |
| September 30, 2023 | -6.427M |
| June 30, 2023 | -6.778M |
| March 31, 2023 | -3.986M |
| December 31, 2022 | -4.648M |
| September 30, 2022 | -4.851M |
| June 30, 2022 | -6.153M |
| March 31, 2022 | -3.697M |
| December 31, 2021 | -5.543M |
| September 30, 2021 | -6.697M |
| June 30, 2021 | -5.357M |
| March 31, 2021 | -8.998M |
| December 31, 2020 | -7.811M |
| September 30, 2020 | -7.012M |
| June 30, 2020 | -5.712M |
| March 31, 2020 | -15.04M |
| December 31, 2019 | -3.624M |
| September 30, 2019 | -3.728M |
| June 30, 2019 | -3.529M |
| March 31, 2019 | -0.839M |
| December 31, 2018 | -3.831M |
| September 30, 2018 | -6.595M |
| June 30, 2018 | -0.16M |
| March 31, 2018 | -2.171M |
| December 31, 2017 | -2.997M |
| Date | Value |
|---|---|
| September 30, 2017 | 3.757M |
| June 30, 2017 | -1.662M |
| March 31, 2017 | -1.642M |
| December 31, 2016 | -1.203M |
| September 30, 2016 | -0.286M |
| June 30, 2016 | -1.465M |
| March 31, 2016 | -3.007M |
| December 31, 2015 | -1.308M |
| September 30, 2015 | -2.542M |
| June 30, 2015 | -1.666M |
| March 31, 2015 | -1.937M |
| December 31, 2014 | -2.074M |
| September 30, 2014 | -1.119M |
| June 30, 2014 | -0.97M |
| March 31, 2014 | -0.485M |
| December 31, 2013 | -1.619M |
| September 30, 2013 | -0.744M |
| June 30, 2013 | -1.109M |
| March 31, 2013 | -0.69M |
| December 31, 2012 | -0.711M |
| September 30, 2012 | -1.088M |
| June 30, 2012 | -0.428M |
| March 31, 2012 | -0.798M |
| December 31, 2011 | -0.481M |
| September 30, 2011 | -0.898M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-15.04M
Minimum
Mar 2020
-3.285M
Maximum
Dec 2023
-5.941M
Average
-5.543M
Median
Dec 2021
Free Cash Flow (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.316M |
| Palatin Technologies Inc | -10.51M |
| iBio Inc | -4.706M |
| Theriva Biologics Inc | -6.597M |
| Oragenics Inc | -1.102M |